Clinical trial endpoint

If you are asking what is a clinical trial endpoint, it is the specific, preplanned outcome a study measures to judge what happened, such as percentage body-weight change after 68 weeks. The endpoint fixes the question before results arrive, so researchers cannot quietly swap in a friendlier measure after seeing the data.

What is the primary endpoint meaning?

The primary endpoint meaning is simple: this is the outcome the trial treats as most important for evaluating the treatment. ClinicalTrials.gov notes that most studies have one, though some have several, and the primary measure is usually used to calculate how many participants the trial needs. It is the main promise, written before the score is known.

A secondary endpoint is another preplanned outcome of interest, but it ranks below the primary one. Secondary results can add useful context. A positive secondary endpoint, however, does not automatically turn a failed primary endpoint into a successful trial. Read the randomized controlled trial definition alongside the endpoint hierarchy: trial design tells you how the comparison was made; endpoints tell you what was compared.

What is a surrogate endpoint?

A surrogate endpoint is a stand-in expected to predict a benefit people actually care about. A blood-pressure reading, scan, or lab marker may be quicker to measure than stroke, symptoms, daily function, or survival. The FDA explains that a surrogate does not itself measure how someone feels, functions, or survives, and its predictive value depends on the specific context.

That distinction matters when reading peptide research. A moved hormone or biomarker proves the marker moved. It does not, by itself, prove more muscle, less pain, or a longer life. Our guide to reading peptide evidence shows where that result belongs on the evidence ladder.

What endpoint did a semaglutide trial use?

Semaglutide’s STEP 1 trial used two co-primary endpoints: percentage change in body weight from baseline to week 68, and the proportion of participants who lost at least 5% of their starting weight. Those measures were registered in advance on ClinicalTrials.gov, then compared between semaglutide and placebo.

That is a clean example because body-weight change directly answers a weight-loss question. The same endpoint would not prove that semaglutide prevents heart attacks; that claim needs cardiovascular events measured in a trial built for that question. The semaglutide profile separates those outcomes instead of letting one result borrow another’s certainty.

How should you read an endpoint claim?

A useful endpoint definition for a clinical trial includes four details: what was measured, when it was measured, whether it was primary or secondary, and whether it was a direct clinical outcome or a surrogate. If a headline omits those details, find the trial record. “The endpoint was met” is only meaningful after you know which endpoint earned the win.